Management of hepatocellular carcinoma: an update

doi:10.1002/hep.24199

Practice Guideline

. 2011 Mar;53(3):1020-2.

doi: 10.1002/hep.24199.

Management of hepatocellular carcinoma: an update

Jordi Bruix¹, Morris Sherman; American Association for the Study of Liver Diseases

Affiliations

PMID: 21374666
PMCID: PMC3084991
DOI: 10.1002/hep.24199

Free PMC article

Practice Guideline

Management of hepatocellular carcinoma: an update

Jordi Bruix et al. Hepatology. 2011 Mar.

Free PMC article

. 2011 Mar;53(3):1020-2.

doi: 10.1002/hep.24199.

Authors

Jordi Bruix¹, Morris Sherman; American Association for the Study of Liver Diseases

Affiliation

¹ Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain. bruix@ub.edu

PMID: 21374666
PMCID: PMC3084991
DOI: 10.1002/hep.24199

No abstract available

PubMed Disclaimer

Figures

**Fig. 1**
Diagnostic algorithm for suspected HCC. CT, computed tomography; MDCT, multidetector CT; MRI, magnetic resonance imaging; US, ultrasound.

**Fig. 2**
The BCLC staging system for HCC. M, metastasis classification; N, node classification; PS, performance status; RFA, radiofrequency ablation; TACE, transarterial chemoembolization.

See this image and copyright information in PMC

Comment in

Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases.
Marrero JA, El-Serag HB. Marrero JA, et al. Hepatology. 2011 Mar;53(3):1060-1; author reply 1061-2. doi: 10.1002/hep.24033. Epub 2010 Dec 28. Hepatology. 2011. PMID: 21374678 No abstract available.
Updated management of hepatocellular carcinoma.
Lo GH. Lo GH. Hepatology. 2011 Sep 2;54(3):1113. doi: 10.1002/hep.24378. Epub 2011 Jul 21. Hepatology. 2011. PMID: 21520202 No abstract available.
Postoperative transcatheter arterial chemoembolization should be recommended in the hepatocellular carcinoma treatment guidelines of the American Association for the Study of Liver Diseases.
Wang Z, Li Z, Ji Y. Wang Z, et al. Hepatology. 2011 Oct;54(4):1489-90. doi: 10.1002/hep.24446. Epub 2011 Jul 21. Hepatology. 2011. PMID: 21618569 No abstract available.

Cited by

Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial.
Duan X, Li H, Kuang D, Chen P, Zhang M, Li T, Jiao D, Li Y, He X, Xing C, Wang H, Liu Y, Xie L, Zhang S, Zhang Q, Zhu P, Chang Y, Xie J, Ren J, Han X. Duan X, et al. Signal Transduct Target Ther. 2024 Nov 13;9(1):304. doi: 10.1038/s41392-024-02012-x. Signal Transduct Target Ther. 2024. PMID: 39532849 Free PMC article. Clinical Trial.
Combination of advanced lung cancer inflammation index and nonalcoholic fatty liver disease fibrosis score as a promising marker for surgical procedure selection for hepatocellular carcinoma.
Hosoda K, Shimizu A, Kubota K, Notake T, Kitagawa N, Yoshizawa T, Sakai H, Hayashi H, Yasukawa K, Soejima Y. Hosoda K, et al. Ann Gastroenterol Surg. 2024 May 20;8(6):1096-1106. doi: 10.1002/ags3.12815. eCollection 2024 Nov. Ann Gastroenterol Surg. 2024. PMID: 39502724 Free PMC article.
Clinical validation of peripheral blood mononuclear cell DNA methylation markers for accurate early detection of hepatocellular carcinoma in Asian patients.
Cheishvili D, Wong C, Karim MM, Golam Kibria M, Jahan N, Chandra Das P, Khair Yousuf A, Islam A, Chandra Das D, Noor-E-Alam SM, Alam S, Rahman M, Khan WA, Al-Mahtab M, Szyf M. Cheishvili D, et al. Commun Med (Lond). 2024 Oct 30;4(1):220. doi: 10.1038/s43856-024-00652-2. Commun Med (Lond). 2024. PMID: 39472687 Free PMC article.
Transarterial Chemoembolization Combined with Microwave Ablation in Elderly Patients with Recurrent Medium or Large Hepatocellular Carcinoma.
Zhang C, Qin Y, Song Y, Liu Y, Zhu X. Zhang C, et al. J Hepatocell Carcinoma. 2024 Oct 22;11:2005-2017. doi: 10.2147/JHC.S455411. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39465044 Free PMC article.
Machine learning-based prediction of pulmonary embolism to reduce unnecessary computed tomography scans in gastrointestinal cancer patients: a retrospective multicenter study.
Kim JS, Kwon D, Kim K, Lee SH, Lee SB, Kim K, Kim D, Lee MW, Park N, Choi JH, Jang ES, Cho IR, Paik WH, Lee JK, Ryu JK, Kim YT. Kim JS, et al. Sci Rep. 2024 Oct 25;14(1):25359. doi: 10.1038/s41598-024-75977-y. Sci Rep. 2024. PMID: 39455658 Free PMC article.

See all "Cited by" articles

References

1. Yuen MF, Tanaka Y, Fong DY, Fung J, Wong DK, Yuen JC, et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol. 2009;50:80–88. - PubMed
1. Yang HI, Sherman M, Su J, Chen PJ, Liaw YF, Iloeje UH, et al. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Clin Oncol. 2010;28:2437–2444. - PubMed
1. Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009;136:138–148. - PMC - PubMed
1. Yeoman AD, Al-Chalabi T, Karani JB, Quaglia A, Devlin J, Mieli-Vergani G, et al. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. Hepatology. 2008;48:863–870. - PubMed
1. Singal A, Volk ML, Waljee A, Salgia R, Higgins P, Rogers MA, et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther. 2009;30:37–47. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information

[1] Yuen MF, Tanaka Y, Fong DY, Fung J, Wong DK, Yuen JC, et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol. 2009;50:80–88. - PubMed

[2] Yuen MF, Tanaka Y, Fong DY, Fung J, Wong DK, Yuen JC, et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol. 2009;50:80–88. - PubMed

[3] Yang HI, Sherman M, Su J, Chen PJ, Liaw YF, Iloeje UH, et al. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Clin Oncol. 2010;28:2437–2444. - PubMed

[4] Yang HI, Sherman M, Su J, Chen PJ, Liaw YF, Iloeje UH, et al. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Clin Oncol. 2010;28:2437–2444. - PubMed

[5] Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009;136:138–148. - PMC - PubMed

[6] Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009;136:138–148. - PMC - PubMed

[7] Yeoman AD, Al-Chalabi T, Karani JB, Quaglia A, Devlin J, Mieli-Vergani G, et al. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. Hepatology. 2008;48:863–870. - PubMed

[8] Yeoman AD, Al-Chalabi T, Karani JB, Quaglia A, Devlin J, Mieli-Vergani G, et al. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. Hepatology. 2008;48:863–870. - PubMed

[9] Singal A, Volk ML, Waljee A, Salgia R, Higgins P, Rogers MA, et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther. 2009;30:37–47. - PMC - PubMed

[10] Singal A, Volk ML, Waljee A, Salgia R, Higgins P, Rogers MA, et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther. 2009;30:37–47. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Management of hepatocellular carcinoma: an update

Affiliation

Management of hepatocellular carcinoma: an update

Authors

Affiliation

Figures

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Figures

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical